CA2761535A1 - Methods for the collection and maturation of oocytes - Google Patents

Methods for the collection and maturation of oocytes Download PDF

Info

Publication number
CA2761535A1
CA2761535A1 CA2761535A CA2761535A CA2761535A1 CA 2761535 A1 CA2761535 A1 CA 2761535A1 CA 2761535 A CA2761535 A CA 2761535A CA 2761535 A CA2761535 A CA 2761535A CA 2761535 A1 CA2761535 A1 CA 2761535A1
Authority
CA
Canada
Prior art keywords
oocyte
maturation
ivm
medium
camp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2761535A
Other languages
English (en)
French (fr)
Inventor
Robert Bruce Gilchrist
Jeremy Thompson
Firas Albuz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innovation and Commercial Partners Pty Ltd
Original Assignee
Adelaide Research and Innovation Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adelaide Research and Innovation Pty Ltd filed Critical Adelaide Research and Innovation Pty Ltd
Publication of CA2761535A1 publication Critical patent/CA2761535A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/31—Pituitary sex hormones, e.g. follicle-stimulating hormone [FSH], luteinising hormone [LH]; Chorionic gonadotropins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA2761535A 2009-05-14 2010-05-14 Methods for the collection and maturation of oocytes Abandoned CA2761535A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17831809P 2009-05-14 2009-05-14
US61/178,318 2009-05-14
PCT/AU2010/000569 WO2010130008A1 (en) 2009-05-14 2010-05-14 Methods for the collection and maturation of oocytes

Publications (1)

Publication Number Publication Date
CA2761535A1 true CA2761535A1 (en) 2010-11-18

Family

ID=43084554

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2761535A Abandoned CA2761535A1 (en) 2009-05-14 2010-05-14 Methods for the collection and maturation of oocytes

Country Status (8)

Country Link
US (1) US20120252119A1 (https=)
EP (1) EP2430154A4 (https=)
JP (1) JP2012526520A (https=)
KR (1) KR20120023097A (https=)
CN (1) CN102482644A (https=)
AU (1) AU2010246918A1 (https=)
CA (1) CA2761535A1 (https=)
WO (1) WO2010130008A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3037101B1 (en) 2014-12-22 2019-03-06 Ferring B.V. Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies
AU2017371402B2 (en) 2016-12-09 2024-02-22 Adelaide university Compositions and methods for maturation of oocytes in vitro
EP3790894B1 (en) 2018-05-09 2024-10-23 Monash University Modified gdf9 polypeptide monomer and method of promoting proliferation and differentiation of granulosa cells and oocyte maturation
KR102005807B1 (ko) 2018-06-25 2019-07-31 단국대학교 산학협력단 난자 성장 장치 및 이를 이용한 난자 성장 방법
CN110305837A (zh) * 2019-06-05 2019-10-08 西北师范大学 磷酸二酯酶5活性抑制剂作为诱导斑马鱼卵母细胞成熟的催熟剂的应用
CN114164168A (zh) * 2021-11-25 2022-03-11 苏州原一医疗科技有限公司 人卵母细胞-卵丘颗粒细胞复合体的体外成熟培养液及培养方法
CN115354019B (zh) * 2022-09-21 2024-03-05 华中农业大学 一种猪卵母细胞体外成熟培养液及其应用
CN115820545A (zh) * 2022-12-28 2023-03-21 中国农业大学 提高卵母细胞体外成熟率的培养基及其应用
CN117338902B (zh) * 2023-10-25 2024-07-09 南京医科大学 一种用于治疗卵子成熟障碍的复方制剂
CN120866198A (zh) * 2025-09-28 2025-10-31 苏州孚甲医疗科技有限公司 一种基于胎球蛋白的ivm无血清培养液

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1235899B1 (en) * 1999-11-25 2007-03-21 Novo Nordisk A/S Treatment of human infertility
DE60321026D1 (de) * 2002-10-15 2008-06-26 Bayer Schering Pharma Ag In-vitro-synchronisation der kern- und zytoplasma-reifung von oozyten mit addition und entfernung von phosphodiesterase-hemmer typ 3
FR2849380A1 (fr) * 2002-12-27 2004-07-02 Ernest Loumaye NOUVELLE UTILISATION D'UN AGONISTE DU GnRH
US7153824B2 (en) * 2003-04-01 2006-12-26 Applied Research Systems Ars Holding N.V. Inhibitors of phosphodiesterases in infertility

Also Published As

Publication number Publication date
US20120252119A1 (en) 2012-10-04
KR20120023097A (ko) 2012-03-12
WO2010130008A1 (en) 2010-11-18
CN102482644A (zh) 2012-05-30
EP2430154A1 (en) 2012-03-21
AU2010246918A1 (en) 2011-12-01
JP2012526520A (ja) 2012-11-01
EP2430154A4 (en) 2014-01-08

Similar Documents

Publication Publication Date Title
US20120252119A1 (en) Methods for the collection and maturation of oocytes
Strączyńska et al. Signaling mechanisms and their regulation during in vivo or in vitro maturation of mammalian oocytes
Cognié et al. State-of-the-art production, conservation and transfer of in-vitro-produced embryos in small ruminants
Akaki et al. Successful piglet production in a chemically defined system for in-vitro production of porcine embryos: dibutyryl cyclic amp and epidermal growth factor-family peptides support in-vitro maturation of oocytes in the absence of gonadotropins
Lima et al. Effect of retinoids and growth factor on in vitro bovine embryos produced under chemically defined conditions
Hasler et al. In vitro fertilization
Chen et al. Schedule to inject in vitro matured oocytes may increase pregnancy after intracytoplasmic sperm injection
Locatelli et al. Successful use of oviduct epithelial cell coculture for in vitro production of viable red deer (Cervus elaphus) embryos
Kharche et al. Factors influencing in-vitro embryo production efficiency of caprine oocytes: A review
Guerif et al. Overnight incubation improves selection of frozen–thawed blastocysts for transfer: preliminary study using supernumerary embryos
Gonzalez-Bulnes et al. Induction of the presence of corpus luteum during superovulatory treatments enhances in vivo and in vitro blastocysts output in sheep
Nowshari et al. 251 CAMELID EMBRYO DEVELOPMENT IN VITRO: EFFECT OF PROTEIN SUPPLEMENT IN MATURATION MEDIUM AND SUBSEQUENT CULTURE IN TWO DIFFERENT MEDIA ON FERTILIZATION AND DEVELOPMENT
US11208622B2 (en) Processing and use of reproductive tract fluids to improve the in vitro production of mammalian embryos
EP1235899B1 (en) Treatment of human infertility
Huang et al. 245 Oocyte recovery by ovum pick up and embryo production in murrah and nili-ravi buffaloes (bubalus bubalis) imported in china
US6544166B1 (en) Treatment of human infertility
Boccia et al. 239 CAPACITATION OF BUFFALO SPERMATOZOA IN VITRO
WO2007012117A1 (en) Compositions and methods for culturing embryos and oocytes
EP3598895A1 (en) An in vitro method for freezing mammalian embryos
AU2003232003B2 (en) Activation of equine oocytes
US20140206930A1 (en) Twinning with sex sorted sperm
Chian et al. Effect of progesterone and/or estradiol-17β on sperm penetration in vitro of bovine oocytes
Hufana-Duran et al. In Vitro Embryo Production in Water Buffalo
Aiudi et al. 261 FERTILITY CONTROL BY GnRH ANALOGUES IN DOGS
McCue et al. 249 EFFECT OF REFREEZING BULL SEMEN ON IVF SUCCESS RATE

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20140514